🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Errors and margins in radiotherapy

M VANHERK (2004)

Seminars in Radiation Oncology

1.2K citesjournal articlePDF

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Kathy S Albain, William E Barlow et al. (2010)

The Lancet Oncology

1.2K citesjournal articlePDF

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

Charles J Ryan, Matthew R Smith et al. (2015)

The Lancet Oncology

1.2K citesjournal articlePDF

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Lorenzo Galluzzi, Juliette Humeau et al. (2020)

Nature Reviews Clinical Oncology

1.3K citesjournal articlePDF

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

G Fyfe, R I Fisher et al. (1995)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Perspectives on cancer therapy-induced mucosal injury

Stephen T. Sonis, Linda S. Elting et al. (2004)

Cancer

1.2K citesjournal articlePDF

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

F. Cardoso, S. Paluch-Shimon et al. (2020)

Annals of Oncology

1.2K citesjournal articlePDF

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Paul W. Sperduto, Norbert Kased et al. (2012)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

Masahiro Fukuoka, Yi-Long Wu et al. (2011)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Immune Checkpoint Inhibitors in Cancer Therapy

Yavar Shiravand, Faezeh Khodadadi et al. (2022)

Current Oncology

1.3K citesjournal articlePDF

Epidemiology of Brain Metastases

Lakshmi Nayak, Eudocia Quant Lee et al. (2011)

Current Oncology Reports

1.2K citesjournal articlePDF

Cancer metabolism: a therapeutic perspective

Ubaldo E. Martinez-Outschoorn, Maria Peiris-Pagés et al. (2016)

Nature Reviews Clinical Oncology

1.2K citesjournal articlePDF

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010

Q. T. Ostrom, H. Gittleman et al. (2013)

Neuro-Oncology

1.2K citesjournal articlePDF

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L Villa, Ronaldo LR Costa et al. (2005)

The Lancet Oncology

1.2K citesjournal articlePDF

First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study

Arjun V Balar, Daniel Castellano et al. (2017)

The Lancet Oncology

1.2K citesjournal articlePDF